Jump to Navigation
Trends and Sentiments
Comments and Analysis
Trading Places: The week's biggest moves
Banking's in her blood: From teller to the top...
As China's Offshore Yuan Crashes To A 2 Year Low,...
Shake Shack workers get in on IPO riches
Debate over sports betting bill shines light on billion-...
Apple Loop: iOS 8.1.3 Angers Users, Outlook Arrives On...
U.S. Cattle Herd Grows, Reversing Trend
The language of love: For professional letter-writer...
Insiders Can't Get Enough Of Greystone Logistics
McD: High fives for free fries?
Are These 10 Sick Healthcare Companies Terminally Ill?
14 Oversold Stocks Trading Near Lows but Being Bought Up by the Smart Money
Top Biotech Picks of High Alpha Funds
5 Healthcare Stocks of Interest This Week
10 Stocks With Bullish Momentum Backed By Strong Top Line Growth
10 Biotech Stocks Being Dumped By Big Money Managers
3 Highly Shorted Biotech Stocks With Strong Institutional Selling
Focus On Entereg; Reiterating Buy On Adolor
Healthcor Management's Latest New And Increased Positions
5 Highly Shorted Healthcare Stocks Being Sold By Smart Money
18 Healthcare Stocks Undervalued By Target Price
10 Biotech Stocks Trading At The Deepest Discounts To Target Price
Analysis Of Institutional 5% Ownership Filings On Friday
Small-Cap, Biotech-Focused Hedge Fund BVF's Top Q3 Picks
Nektar Therapeutics: Often Forgotten, But Worth A Look
12 Healthcare Stocks With Bearish Short Trends
Buy Biotech In Phase II For The Best Upside
What's It Going To Take To Get Salix Cheap?
The Age Of Personalized Medicine Has Arrived
20 Biotech Stocks Being Bought Up By Hedge Funds
A Small-Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
Long Undervalued, Is Alkermes Still A Bargain?
Why The Markets Continue To Coalesce Around New Approaches To Treating Cancer
5 Hedge Fund Biotech Stock Picks With Significant Short Covering
Home sweet homewreck: This is the worst reno...
‘We don’t call it ‘Maui Wowie”: Why Canadian pot...
EUR/GBP: 1.3351 USD/EUR: 1.1285 JPY/USD: 117.555
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions